Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of platelet-activating factor (PAF) on human platelets

C M Chesney, D D Pifer, L W Byers

    Blood
    |March 1, 1982
    PubMed
    Summary

    Platelet-activating factor (PAF) causes human platelet aggregation and serotonin release, primarily through the cyclo-oxygenase pathway. This effect is inhibited by metabolic and membrane-active drugs, suggesting a key role for this pathway in PAF

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PATHOLOGY OF CARDIOVASCULAR DISEASE.

    A listing of research in the cardiovascular field·2014
    Same author

    Parenteral administration of fluids during the early care of battle casualties.

    Archives of surgery (Chicago, Ill. : 1920)·2010
    Same author

    Practical observations on the copper sulfate method for determining the specific gravities of whole blood and serum.

    Surgery, gynecology & obstetrics·2010
    Same author

    Peritoneal irrigation for uremia following incompatible blood transfusion; report of a case.

    Archives of surgery (Chicago, Ill. : 1920)·2010
    Same author

    Burn case; intrasternal administration of plasma; sulfadiazine complications.

    The Dallas medical journal·2010
    Same author

    Sodium and potassium determinations in health and disease.

    The Journal of laboratory and clinical medicine·2010

    Area of Science:

    • Biochemistry
    • Hematology
    • Pharmacology

    Background:

    • Platelet-activating factor (PAF) is a potent lipid mediator.
    • Its precise role in human platelet activation requires further elucidation.

    Purpose of the Study:

    • To investigate the effects of synthetic PAF on human platelet aggregation and secretion.
    • To identify the signaling pathways involved in PAF-mediated platelet activation.

    Main Methods:

    • Studied PAF effects on human platelet-rich plasma (PRP) and gel-filtered platelets (GFP).
    • Measured platelet aggregation, 14C-serotonin release, and platelet factor 4 (PF4) secretion.
    • Assessed the impact of various inhibitors, including metabolic inhibitors, membrane-active drugs, PGI2, indomethacin, aspirin, and ADP scavengers.

    Main Results:

    • PAF induced dose-dependent platelet aggregation and secretion of 14C-serotonin and PF4.
    • Aggregation and secretion were inhibited by metabolic inhibitors, membrane-active drugs, and cyclo-oxygenase inhibitors (indomethacin, aspirin).
    • ADP scavengers inhibited the secondary aggregation wave but not secretion.

    Conclusions:

    • PAF's primary effect on human platelets is mediated via the cyclo-oxygenase pathway.
    • These findings differentiate PAF's mechanism from other platelet activation pathways.

    Related Experiment Videos